Navigation Links
GranuFlo Lawsuits Move Forward, as Federal Court Adopts Master Complaint for all Claims Filed in Wake of GranuFlo and NaturaLyte Recall, Bernstein Liebhard LLP Reports
Date:1/3/2014

New York, New York (PRWEB) January 03, 2014

GranuFlo lawsuits (http://www.thegranuflolawsuit.com/ ) filed on behalf of individuals who allegedly suffered heart attacks, strokes, sudden cardiac death, and other serious heart injuries following administration of GranuFlo and NaturaLyte dialysis concentrates continue to move forward in a federal multidistrict litigation underway in U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP reports. According to a Case Management Order issued on December 23, 2013, the Court has approved the use of a Master Complaint and Short Form Complaint for all claims filed in the proceeding. The Master Complaint details common allegations raised in all dialysis lawsuits stemming from the 2012 GranuFlo and NaturaLyte recall. All future plaintiffs will be able to use the Short Form Complaint to indicate which dialysis drug they were treated with, what injuries they are alleging, and what specific allegations from the Master Complaint they are adopting. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)

“Our Firm is representing numerous individuals who allegedly suffered catastrophic heart injuries related to the GranuFlo recall. The adoption of the Master and Short Form Complaints will do much to streamline the process for filing GranuFlo or NaturaLyte lawsuits,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free GranuFlo lawsuit evaluations to dialysis patients who allegedly suffered cardiac arrest, heart attacks, stroke, sudden cardiac death or other side effects within 72 hours of a dialysis treatment involving the use of GranuFlo of NaturaLyte.

GranuFlo Lawsuits
Court documents indicate that at least 433 GranuFlo lawsuits have been filed thus far in the litigation underway in the District of Massachusetts. All of the lawsuits similarly allege that Fresenius failed to provide adequate warnings regarding the risks associated with GranuFlo and NaturaLyte, and that the company continued to aggressively market the products even once it became aware of those risks.

On March 2012, Fresenius Medical Care, the manufacturer of GranuFlo and NaturaLyte, issued an Urgent Product Notification for both products that warned of dosage issues that could cause dialysis patients to suffer serious and catastrophic heart side effects. The New York Times reported in June 2012 that many doctors did not know that GranuFlo and NaturaLyte were manufactured differently than rival dialysis drugs, and contained more of an ingredient the body converts to bicarbonate. If a prescribing physician did not account for this difference, there existed a risk that patients would develop a dangerous elevation of bicarbonate in their blood known as metabolic alkalosis. This condition can result in sudden and life-threatening heart problems, including heart attacks, strokes, and sudden cardiac death, during or shortly after treatments.*

Fresenius’ Urgent Product Notification was eventually granted Class I recall status by the U.S. Food & Drug Administration (FDA), a designation that is given to medical products that pose a risk of serious injury or death. The New York Times has also reported that the agency launched a probe of Fresenius Medical Care after it became aware of an internal memo circulated by the company to its in-network dialysis clinics in November 2011 that detailed potential risks linked to GranuFlo and NaturaLyte. The FDA is trying to determine if Fresenius should have issued a nationwide warning about the two drugs earlier than it did.*

Individuals who allegedly suffered a catastrophic heart event within 72 hours of a dialysis treatment that involved GranuFlo or NaturaLyte may be entitled to file a GranuFlo lawsuit against Fresenius Medical Care. To learn more about the serious heart side effects behind the GranuFlo recall, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For additional information, and to arrange for a free case review, please call 800-511-5092.

*nytimes.com/2012/06/15/health/fda-investigates-fresenius-for-failure-to-warn-of-risk.html; New York Times, June 14, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.thegranuflolawsuit.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/granuflo-lawsuit/granuflo-recall/prweb11460506.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
2. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
3. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
4. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
5. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
6. New Granuflo Cardiac Arrest Lawsuit: Now, AttorneyOne Can Provide Advice
7. GranuFlo Lawsuit News: Bernstein Liebhard LLP Reports on Growing Litigation Surrounding GranuFlo Recall
8. Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama
9. GranuFlo Lawsuits Moving Forward in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
10. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard Notes Issuance of New Order in Federal GranuFlo Recall Litigation
11. GranuFlo Lawsuit News: W.Va. Man’s Lawsuit Goes to Federal Court, Rottenstein Law Group LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2019)... ... , ... Infertility is an issue for 1 in 6 couples; in about 50% of these ... sharp decline in male sperm count over the last 40 years was featured in articles ... panic that we are in the midst of a severe, perhaps irreversible, male infertility crisis. ...
(Date:2/13/2019)... ... February 13, 2019 , ... A Place at Home has received ... Pulse. The Employer of Choice Award is granted only to the top-ranking home care ... research firm for home care. A Place at Home is ranked among the best ...
(Date:2/13/2019)... Calif. (PRWEB) , ... February 13, 2019 , ... Asana ... scholarship. Open to students who choose to pursue a medical-related course of study in ... their passion for substance abuse disorder and mental health treatment, and how it has ...
(Date:2/13/2019)... SANTA MONICA, Calif. (PRWEB) , ... February 13, ... ... Surgeon of Southern California has joined the esteemed Haute Beauty network. , ... is privileged to present Dr. Christie as a leading Aesthetic surgeon and our ...
(Date:2/12/2019)... ... February 12, 2019 , ... A technology company that aims ... visit, won the top award at the 9th annual SPIE Startup Challenge at ... winning pitch, nabbing a combined first prize of $15,000. Radiance 4D’s revolutionary 3D ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... ... February 13, 2019 , ... ... population health reporting solutions, is launching IMAT 8.0, its latest health data platform, ... a more streamlined user interface and dynamic single-query builder, IMAT 8.0 allows HIEs, ...
(Date:2/13/2019)... ... February 13, 2019 , ... Abu ... Public Private Partnership (PPP) between the Department of Health-Abu Dhabi (DoH) and Injazat ... Health Information Exchange system (HIE), a centralized platform to streamline healthcare connectivity for ...
(Date:2/13/2019)... ... February 13, 2019 , ... Co-founded in a parking lot by ... women an empowering place to not only exercise, but to nurture their mental and ... a former professional baseball player with the San Francisco Giants and COO Morgan brings ...
Breaking Medicine Technology: